Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/55540
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12978]
Metadata
Show full item record
IMMUNOGENICITY OF CONJUGATED AND POLYSACCHARIDE PNEUMOCOCCAL VACCINES ADMINISTERED DURING PREGNANCY OR POSTPARTUM TO WOMEN WITH HIV
Author
Duarte, Geraldo
Muresan, Petronella
Ward, Shawn
Laimon, Lauren
Pelton, Stephen I.
Canniff, Jennifer
Golner, Amanda Golner
Bone, Frederic
Newton, Lassallete
Fenton, Terence
Coutinho, Conrado M.
João, Esau C.
Santos, Breno R.
Pilotto, Jose Henrique da Silva
Oliveira, Ricardo H.
Pinto, Jorge A.
Machado, Elizabeth S.
Kreitchman, Regis
Chakhtoura, Nahida
Mussi-Pinhata, Marisa M.
Weinberg, Adriana
for NICHD P1091 Study Team
Muresan, Petronella
Ward, Shawn
Laimon, Lauren
Pelton, Stephen I.
Canniff, Jennifer
Golner, Amanda Golner
Bone, Frederic
Newton, Lassallete
Fenton, Terence
Coutinho, Conrado M.
João, Esau C.
Santos, Breno R.
Pilotto, Jose Henrique da Silva
Oliveira, Ricardo H.
Pinto, Jorge A.
Machado, Elizabeth S.
Kreitchman, Regis
Chakhtoura, Nahida
Mussi-Pinhata, Marisa M.
Weinberg, Adriana
for NICHD P1091 Study Team
Affilliation
Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Ginecologia e Obstetrícia. Ribeirão Preto, SP, Brasil.
Frontier Science Foundation. Brookline, Massachusetts, USA.
Frontier Science Foundation. Brookline, Massachusetts, USA.
Westat, Rockville. Maryland, USA.
Boston University School of Medicine. Boston, Massachusetts, USA.
Department of Pediatrics, University of Colorado Anschutz Medical Campus. Aurora, Colorado, USA.
Frontier Science Foundation. Buffalo, New York, USA.
Frontier Science Foundation. Buffalo, New York, USA.
Westat, Rockville. Maryland, USA.
Frontier Science Foundation. Brookline, Massachusetts, USA.
Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Ginecologia e Obstetrícia. Ribeirão Preto, SP, Brasil.
Hospital dos Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Hospital Nossa Senhora da Conceicao. Porto Alegre, RS, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Hospital Geral de Nova Iguaçu. Nova Iguaçu, RJ, Brasil.
Instituto de Puericultura e Pediatra Matagão Gesteira. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Escola de Medicina. Belo Horizonte, MG, Brasil.
Instituto de Puericultura e Pediatra Matagão Gesteira. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Ciências da Saúde de Porto Alegre. Porto Alegre, RS, Brasil.
Eunice Kennedy Shriver National Institute of Child Health and Human Development. Bethesda, Maryland, USA.
Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Pediatria. Ribeirão Preto, SP, Brasil.
Department of Pediatrics, University of Colorado Anschutz Medical Campus. Aurora, Colorado, USA.
for NICHD P1091 Study Team
Frontier Science Foundation. Brookline, Massachusetts, USA.
Frontier Science Foundation. Brookline, Massachusetts, USA.
Westat, Rockville. Maryland, USA.
Boston University School of Medicine. Boston, Massachusetts, USA.
Department of Pediatrics, University of Colorado Anschutz Medical Campus. Aurora, Colorado, USA.
Frontier Science Foundation. Buffalo, New York, USA.
Frontier Science Foundation. Buffalo, New York, USA.
Westat, Rockville. Maryland, USA.
Frontier Science Foundation. Brookline, Massachusetts, USA.
Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Ginecologia e Obstetrícia. Ribeirão Preto, SP, Brasil.
Hospital dos Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Hospital Nossa Senhora da Conceicao. Porto Alegre, RS, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Hospital Geral de Nova Iguaçu. Nova Iguaçu, RJ, Brasil.
Instituto de Puericultura e Pediatra Matagão Gesteira. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Escola de Medicina. Belo Horizonte, MG, Brasil.
Instituto de Puericultura e Pediatra Matagão Gesteira. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Ciências da Saúde de Porto Alegre. Porto Alegre, RS, Brasil.
Eunice Kennedy Shriver National Institute of Child Health and Human Development. Bethesda, Maryland, USA.
Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Pediatria. Ribeirão Preto, SP, Brasil.
Department of Pediatrics, University of Colorado Anschutz Medical Campus. Aurora, Colorado, USA.
for NICHD P1091 Study Team
Abstract
Background. Pneumococcal vaccination is recommended in people with HIV, prioritizing PCV. We compared the immunogenicity
of PCV-10 and PPV-23 administered antepartum or postpartum.
Methods. This double-blind study randomized 346 pregnant women with HIV on antiretrovirals to PCV-10, PPV-23, or placebo
at 14–34 weeks gestational age. Women who received placebo antepartum were randomized at 24 weeks postpartum to PCV-10 or
PPV-23. Antibodies against 7 serotypes common to both vaccines and 1 serotype only in PPV-23 were measured by ELISA/chemiluminescence;
B- and T-cell responses to serotype 1 by FLUOROSPOT; and plasma cytokines/chemokines by chemiluminescence.
Results. Antibody responses were higher after postpartum versus antepartum vaccination. PCV-10 generated lower antibody
levels than PPV-23 against 4 and higher against 1 of 7 common serotypes. Additional factors associated with high postvaccination
antibody concentrations were high prevaccination antibody concentrations and CD4+ cells; low CD8+ cells and plasma HIV RNA;
and several plasma cytokines/chemokines. Serotype 1 B- and T-cell memory did not increase after vaccination.
Conclusions. Antepartum immunization generated suboptimal antibody responses, suggesting that postpartum booster doses
may be beneficial and warrant further studies. Considering that PCV-10 and PPV-23 had similar immunogenicity, but PPV-23 covered
more serotypes, use of PPV-23 may be prioritized in women with HIV on antiretroviral therapy.
Share